Probiotic May Help Prevent Ventilator-Associated Pneumonia

Reading Time: < 1 minute

As prophylaxis against ventilator-associated pneumonia, the probiotic bacterium Lactobacillus plantarum 299 (Lp299) is as effective as the antiseptic chlorhexidine in reducing the pathogenic bacterial load in the oropharynx of tracheally intubated, mechanically ventilated, critically ill patients, results of a pilot study indicate.

Comment: Using Lp299 in oral decontamination procedures is “microbiologically attractive.” “As the bacteria adhere to the oral mucosa, they are able to counteract potentially pathogenic bacteria around the clock, which is superior to the fairly short-term effect of orally applied chemical agents,”

Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care. 2008;12(6):R136. Epub 2008 Nov 6. View Abstract View Full Paper

Previous Post
Trials of complementary and alternative medicine may not sway many clinicians
Next Post
Effect of interpretive bias on research evidence

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Menu